NextGen's Medfusion Buyout To Improve Patient Experience
Zacks Investment Research | Nov 13, 2019 08:08PM ET
NextGen Healthcare, Inc. (NASDAQ:NXGN) recently announced an agreement to acquire Medfusion for a deal value of $43 million, to be paid in cash. The acquisition is expected to close in December 2019. Notably, the buyout will fortify NextGen’s foothold in the global healthcare information technology (HCIT) space.
For investors’ notice, North Carolina-based Medfusion is an HCIT leader whose patient experience platform caters to patient needs and enables retrieving and aggregating of patient data from electronic health records (EHR).
Rationale Behind the Deal
HCIT solutions are emerging as powerful tools to curtail healthcare costs while improving healthcare quality.
The latest buyout is likely to actively involve NextGen’s patients in making choices based on both cost and quality. This will enable high-quality healthcare apart from driving patient engagement.
Notably, Medfusion’s patient experience platform is a modern portal with an attractive, easy-to-use interface designed to run on any device. The platform includes powerful capabilities for patient intake, patient scheduling and patient payment capabilities and is used by more than 16 million patients.
Market Prospects
.
DexCom’s fourth-quarter earnings growth is projected at 29.6%.
CONMED’s long-term earnings growth rate is expected to be 17%.
DENTSPLY’s long-term earnings growth rate is estimated at 11.6%.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
Original post
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.